Advise MedMedical Advices

If you're new here, you may want to subscribe to my RSS feed. Thanks for visiting!

KING OF PRUSSIA, Pa., July 17 /PRNewswire/ — health Market Science, Inc., a leading source of healthcare provider data and analytics solutions in the United States, announced today the launch of Clinical Investigators, their latest innovation for clinical site recruitment. Clinical Investigators dramatically reduces the time needed by pharmaceutical companies and contract research organizations (CRO’s) to recruit physicians for clinical trials by providing instant online access to one of the industry’s most comprehensive, up-to-date national databases of physician reference data, clinical trial experience, and claims volume rankings.
(Logo: )
“With more than 80% of clinical trials experiencing delays, the industry is looking for insight into how trial site selection can become a more effective, efficient and repeatable process,” says Zach Henderson, Vice President, Marketing and Product Development at health Market Science. “Clinical Investigators provides our clients a competitive advantage by accelerating the identification and recruitment of the best investigators for their trial protocol.
“Clinical operations executives continue to face the increased pressures of heightened regulatory scrutiny of trial results, soaring R&D costs, and the need to accelerate the time-to-market for new drugs. Clinical Investigators allows users to immediately begin their planning for site recruitment or aid them in the implementation of an effective rescue plan to get their trial back on target as well as reduce additional costs and time delays.
Clinical Investigators links an intuitive web-based user interface with a national, comprehensive database of trial experience detail, claims data, and health Market Science’s Provider Master File. With over 4.5 million individual providers and 1.0 million healthcare organizations, the health Market Science Provider Master File is a trusted source of physician site detail and affiliations.
About health Market Science
Health Market Science is the leading source for healthcare provider data and advanced analytics in the United States. health Market Science has developed unique technology and expertise to continuously acquire, analyze, and integrate over 2,500 distinct data sources to create and maintain the single most comprehensive and accurate source of healthcare provider information available today. The HMS MasterFile(TM) includes detailed reference information for over 4.5 million individual providers and 1.0 million healthcare organizations.
Serving all segments of healthcare, including pharmaceutical manufacturers, biotechs, device manufacturers, payers, providers, and pharmacy chains, health Market Science is the only company that offers claims information, advanced analytics and the reference data that powers them. This unique combination results in dramatically higher data accuracy and reliability, enabling our customers to increase revenues, drive operational efficiencies, achieve regulatory compliance, and maximize market opportunities.
Recognized on the Inc. 500 as one of the fastest growing private companies in the United States and 10th on Deloitte’s Technology Fast 50 Program for Greater Philadelphia, our more than 200 customers include 20 of the top 20 pharmaceutical manufacturers, 10 of the 15 largest device manufacturers, and 3 of the top 5 pharmacy chains. health Market Science is a privately held company located in King of Prussia, PA. For more information, visit . For more information on Clinical Investigators go to

Health Market Science, Inc.

WASHINGTON, July 16 /PRNewswire-USNewswire/ — Two new studies published online today in the American Journal of Public health demonstrate the critical need for Congress to enact pending legislation granting the U.S. Food and Drug Administration (FDA) regulatory authority over tobacco products. One study found that tobacco companies deliberately manipulate levels of menthol in cigarettes in ways the authors conclude recruit new, young smokers and satisfy long-term smokers. The second study found that tobacco companies, because of public relations and litigation concerns, suppressed their own internal research about the presence of polonium-210, a radioactive, cancer-causing chemical, in cigarettes and cigarette smoke.
These studies demonstrate how the current lack of regulation allows tobacco companies to manipulate their products in ways harmful to health and to control what is in their products and what they disclose about them. Currently, no government agency has the authority to regulate menthol, polonium-210 or any of the more than 4,000 chemicals in a cigarette. The legislation before Congress would fundamentally change this harmful status quo by granting the FDA authority over the manufacturing and marketing of tobacco products. For the first time, decisions about tobacco products would be made to protect public health rather than to maximize the profits of the tobacco industry.
Under this legislation, the FDA would gain critical authority to curtail the tobacco industry’s harmful practices. Among other things, the legislation would:
– Require tobacco companies to disclose the contents of tobacco products, changes to their products and research about their products.
– Empower the FDA to require changes in tobacco products, such as the elimination or reduction of harmful chemicals. This includes the authority to regulate the use of menthol in cigarettes, including banning menthol entirely if the FDA determines this will protect public health.
– Curtail tobacco marketing, especially to children. Among other things, the bill would limit tobacco advertising in stores and in magazines with significant teen readership to black-and-white text only; require stores to place tobacco products behind the counter; ban all remaining tobacco brand sponsorships of sports and entertainment events; and ban free cigarette samples and free giveaways of non-tobacco items with the purchase of a tobacco product. Importantly, this legislation would for the first time in 40 years return to the states the authority to regulate cigarette marketing. States and localities could impose bans or restrictions on the time, place and manner (but not content) of the advertising or promotion of cigarettes. These steps will restrict both tobacco marketing to children in general and the targeted marketing of menthol cigarettes that has been so harmful to the African-American community.
– Require larger, more effective health warnings on tobacco products and give the FDA the authority to revise warnings to reflect emerging concerns such as polonium-210. Currently, it requires an act of Congress to change tobacco health warnings.
This legislation has been sponsored by a majority of both the House and the Senate, has been endorsed by more than 680 public health, faith and other organizations around the country, and is supported by 70 percent of American voters. These new studies demonstrate why it is critical that Congress act now to grant the FDA long-overdue authority over tobacco products and address the number one cause of preventable death in the United States. Tobacco use kills more than 400,000 Americans and costs the nation nearly $100 billion in health care bills each year.
More information on the two studies:
Menthol study: This study, by researchers at the Harvard School of Public Health, found that tobacco companies deliberately manipulate menthol levels in cigarettes in ways that appeal to different smokers. The companies developed and marketed cigarettes with lower levels of menthol and milder perceived menthol sensation that appeal to younger smokers. More established smokers preferred cigarettes with higher menthol levels. For new or younger smokers, menthol masks the harshness and discomfort of inhaling smoke. The study concludes, “To protect the public health, tobacco products should be federally regulated, and additives such as menthol should be included in that regulation.”
Polonium-210 study: This study, by researchers at the Mayo Clinic and Stanford University, found that tobacco companies suppressed publication of their own internal research about the presence and potential health effects of radioactive, cancer-causing polonium-210 in cigarettes and cigarette smoke. Based on a review of internal tobacco industry documents, the study found that tobacco companies for 40 years have been concerned about the public relations and litigation problems posed by polonium-210 in cigarettes and sought to avoid public attention to the issue for fear of “waking a sleeping giant,” as one Philip Morris document put it. The study found that tobacco companies “continue to minimize its [polonium-210's] importance in smoking and health litigation and remain silent on the issue on their Web sites and in their messages to consumers.”
Citing prior research, the study states, “It is estimated that smokers of 1.5 packs of cigarettes a day are exposed to as much radiation as they would receive from 300 chest X-rays a year. PO-210 has been estimated to be responsible for 1% of all U.S. lung cancers…. PO-210 may be responsible for more than 1,600 deaths in the United States and 11,700 deaths in the world every year.” Polonium-210 received significant media attention in 2006 when it was found to have been used in the fatal poisoning of former KGB agent Alexander V. Litvinenko.
March 2007 polling conducted for the Campaign for Tobacco-Free Kids found that 92 percent of teens and 91 percent of adults did not know that polonium-210 was found in cigarettes and cigarette smoke. When presented with a list of chemicals in cigarette smoke and asked to choose which they feared most, 30 percent of teens and 29 percent of adults chose polonium-210, more than any other chemical.
The studies will be available on the web site of the American Journal of Public health at .
Campaign for Tobacco-Free Kids

ATLANTA, July 16 /PRNewswire/ — MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, today announced the appointment of Gregory A. Buchholz to the newly created position of chief operating officer. In this new role, Buchholz will be responsible for all aspects of operations at MDdatacor.
Buchholz will oversee the quality assurance, project management, informatics, data processing and information technology departments. In particular, his focus will be on ensuring the scalability of MDdatacor’s CareInformatix(TM) technology platform to accommodate the rapidly expanding customer base.
“Greg is an accomplished executive who has demonstrated strong leadership and strategic vision,” said MDdatacor co-founder, president and chief executive officer Tim Roche. “We are pleased to have found an individual with Buchholz’s extensive experience in information technology and operations management. He will play a key role in scaling the organization for future success.”
Buchholz most recently served as president and chief operating officer for Method IQ, Inc. He co-founded the company, which provided custom software applications and professional services to complex contact center operations, primarily in the health care and financial sectors. From its early days, he successfully planned and led software development, professional services and operations teams through the company’s rapid growth and recent sale to Charys Holding Company.
Prior to Method IQ, Buchholz co-founded Loyalistics.com, an ASP deployed customer relationship management software and professional services firm. Through these entrepreneurial endeavors, he brings to MDdatacor over 20 years of experience building highly scalable technology and delivery platforms.
Buchholz is a former member of Vistage International, the leading organization dedicated to the professional development of senior leaders throughout the world, and remains active in the Vistage community and numerous contact center and technology-related trade groups throughout the southeastern United States.
“I am very excited about the opportunity Tim and the other senior leaders of MDdatacor have entrusted to me. The company has achieved remarkable growth, both in terms of market share and advancing their technology. I look forward to becoming an integral part of this team as we collaborate with our clients to improve the quality of health care.”
About MDdatacor
Established in 2001 and headquartered in Atlanta, Georgia, MDdatacor enhances healthcare quality through the development of innovative technology solutions. MDdatacor solutions are used to support quality improvement, health information exchange and Patient-Centered Medical Home initiatives. MDdatacor currently serves more than 7,000 physicians representing more than seven million patients. For more information, visit or call (866) 460-5681.
Contact:
Heather McLarney
(866) 460-5681

MDdatacor, Inc.

GREAT RIVER, N.Y., July 15 /PRNewswire/ — Netsmart Technologies, Inc., a leading provider of enterprise-wide software and services for health and human services organizations, today announced dates for a special Web seminar to help behavioral health organizations understand electronic prescribing and the new Medicare bill passed by the U.S. House of Representatives and the Senate that provides financial incentives to physicians that use e-prescribing technology.
The bill includes a two percent incentive for physicians who use electronic prescribing starting in 2009 and a two percent pay cut for Medicare-participating physicians who do not adopt e-prescribing by 2012. The electronic prescribing measures are part of H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008. The bill is considered “veto-proof” because of its margin of passage, and has been sent to the President for his signature.
The Netsmart Web seminar will focus on helping organizations understand how e-prescribing works and to achieve the benefits of e-prescribing. The Web seminar will be offered at several times:
— Wednesday, July 23, Noon ET
— Friday, August 1, 2:00 p.m. ET
— Monday, August 11, 3:00 p.m. ET
— Tuesday, August 19, 4:00 p.m. ET
— Thursday, August 21, 11:00 a.m. ET

Netsmart’s InfoScriber e-prescribing solution will help behavioral health clinical staff achieve the e-prescribing-related benefits associated with H.R. 6331 and take advantage of the new incentives. InfoScriber is a secure, Web-based prescribing and medication management system developed for the unique requirements of behavioral health providers. InfoScriber checks drug interactions automatically at the time of prescribing and then routes the prescription electronically to the pharmacy of choice via the Pharmacy health Information Exchange operated by SureScripts.
InfoScriber can be used as a stand-alone application or linked with an organization’s existing clinical systems to securely share demographic and medication information. InfoScriber is also integrated with Netsmart’s Avatar, CMHC/MIS and Helper behavioral health practice management solutions to provide e-prescribing capabilities for users of those solutions. In addition to its e-prescribing functions, InfoScriber features a variety of medication management functions, including reporting capabilities that help reduce polypharmacy and medication interaction risks.
“We are in a unique position to help providers take advantage of these new Medicare incentives because we provide the only e-prescribing solution in the market specifically designed for behavioral health,” said James L. Conway, chief executive officer, Netsmart Technologies. “If an organization or practice is not using e-prescribing now, they must look at this bill as the catalyst to start prescribing electronically and realize the benefits to their consumers of reducing the possibility of medication errors and the opportunity to improve quality of care.”
To register for the Netsmart e-prescribing Web seminar or to learn more, visit or call 1-800-421-7503.
Note: Listen to a podcast () about this legislation and e-prescribing with Chuck Klein, Ph.D., Netsmart’s director of Clinical Services and InfoScriber Operations.
About Netsmart Technologies, Inc.
Netsmart Technologies is an established, leading supplier of enterprise-wide software solutions for health and human services providers. More than 18,000 customer organizations, including 350,000 care providers and nearly 40 state systems, use Netsmart products to help improve the quality of life for millions of people each year.
Netsmart’s customers include mental health and substance abuse treatment agencies, psychiatric hospitals, private and group mental health practices, public health departments, vital records offices and managed care organizations. Netsmart’s products are full-featured information systems that operate on a variety of operating systems, hardware platforms, and mobile devices, and offer unlimited scalability.
Netsmart’s Connected Care initiative allows behavioral and public healthcare providers to share clinical data electronically within their internal processes, externally with other providers, and with consumers via a Web-based portal, enabling high quality, consumer-directed care.
Pharmacy health Information Exchange is a trademark of SureScripts.
Netsmart Technologies, Inc.

CHICAGO, July 15 /PRNewswire/ — The 100 Most Wired hospitals show better outcomes in patient satisfaction, risk-adjusted mortality rates and other key quality measures through the use of information technology (IT), according to a new analysis. Marking its 10th year, the Most Wired Survey and Benchmarking Study continues to lead the field in analyses and benchmarking of healthcare IT.
“Health IT has shown incredible promise in helping us improve the quality and safety of the care hospitals deliver every day,” said Rich Umbdenstock, president and CEO of the American Hospital Association. “The results of the Most Wired survey confirm that today’s patient also understands the benefits of IT in improving care and improving the overall hospital experience.”
“Today’s results add to the growing evidence that the appropriate use of IT can enhance both quality and patient satisfaction,” said Alden Solovy, executive editor of Hospitals & health Networks magazine. “Most Wired hospitals are proving the fundamental value of information technology.”
The analysis shows that better outcomes occur among high tech hospitals, but it does not establish a direct causal relationship between technology and outcomes. The satisfaction analysis was conducted jointly with Press Ganey Associates and the quality analysis was conducted jointly with Thomson Healthcare.
“Quality and satisfaction are often tied to key initiatives and goals that hospitals are striving towards through the use of technology and process improvement,” said Merrie Wallace, R.N., vice president and solution line manager, McKesson Provider Technologies. “The most successful hospitals use technology as part of an overall strategy and achieve significant results. Those that just deploy technology for technology’s sake don’t see these types of results.”
Lydon Neumann, senior executive at Accenture LLC, agreed that investment in information technology needs to be coupled with other hospital or system-wide efforts to drive exceptional results. “Most Wired hospitals excel in many ways but a strong investment in and commitment to information technology are characteristic of leaders who are looking at all of the elements needed to be a high-performing organization,” Neumann said.
“An investment in information technology demonstrates the organizational commitment to patients, caregivers, physicians and clinicians, staff and administration,” said Neumann. “It indicates a willingness to invest in areas that advance organizational effectiveness.”
The Most Wired Survey is conducted annually by Hospitals & health Networks magazine, the journal of the American Hospital Association, which uses the results to name the 100 Most Wired hospitals and health systems. It focuses on how the nation’s hospitals use information technologies for quality, customer service, public health and safety, business processes and workforce issues.
Hospitals & health Networks conducted the 2008 survey in cooperation with Accenture, McKesson Corp. and the College of Healthcare Information Management Executives. The July H&HN cover story detailing results is available at .
About the Most Wired Survey and Benchmarking Study
Hospitals & health Networks, the journal of the American Hospital Association, conducts the voluntary Most Wired Survey and Benchmarking Study annually and names the 100 Most Wired.
Accenture is a global management consulting, technology services and outsourcing company.
McKesson Corporation is the world’s largest healthcare services, technology and automation company.
CHIME was formed with the dual objective of serving the professional development needs of healthcare chief information officers and advocating the more effective use of information management within health care.
For information contact:
Sarah B. Brown
health Forum
(312) 893-6894

Hospitals & health Networks

PITTSBURGH, July 15 /PRNewswire/ — MED3OOO Group, Inc. (MED3OOO), a national leader in healthcare management and technology products and services for providers and employers, is pleased to announce the addition of Thomas P. Cooper, M.D., a nationally recognized healthcare entrepreneur, to MED3OOO’s Board of Directors.
MED3OOO recently announced partnership arrangement with Mitsui & Co. (USA), Inc., a wholly owned subsidiary of Mitsui & Co., Ltd. (Mitsui). The agreement with Mitsui provides MED3OOO with opportunities to expand its vision of being a global “premier strategic operations partner” for those involved in the delivery and financing of healthcare. Dr. Cooper will be joining other outside MED3OOO Board members, which include John McConnell (founder and former CEO of Medic Computer Systems, now Misys Healthcare, and former CEO of A4 health Systems, now Allscripts), Scott Miller, Managing Partner and cofounder of Lovett Miller & Co., a private equity company, and Rick Salas, investor and director of Medical Manager Systems and former CEO of iLIANT Inc.
Dr. Cooper has used his medical training and business acumen to start up and manage several companies that have become national leaders in their respective fields. He founded a national emergency physician company (Spectrum Emergency Care, acquired by Laidlaw, Inc.), the largest correctional facility healthcare company (Correctional Medical Services), the leading provider of mental health programs for long-term care facilities (Vericare), and the largest provider of X-Ray/EKG to nursing homes (Mobilex USA, acquired by Integrated health Services). These companies have had combined revenues of over $1 billion, serve over five-thousand facilities, and are located in all 50 states, reaching more than four million patients. Dr. Cooper is an Adjunct Professor at Columbia Business School, where he teaches courses on entrepreneurship, and he serves on the Boards of Hanger Orthopedic, Kindred Healthcare, and IPC The Hospitalist Company. He is also actively involved with other portfolio companies of Aperture Venture Partners, a venture capital firm where he is a senior partner.
“We are excited to have Dr. Cooper’s expertise on our board, given his vast leadership experience and knowledge in building and operating successful companies within the healthcare industry. We believe he will provide valuable strategic direction to MED3OOO,” said Patrick V. Hampson, Chairman and CEO of MED3OOO.
About MED3OOO
MED3OOO, a leader in healthcare management services, information management, and technologies, advances the quality and performance of healthcare delivery for providers and payors across the United States. Focused on the provision of evidence-based management and population health management, MED3OOO empowers over 15,000 physician, hospital, employer, health system, and municipal clients across the United States. For more information, please visit or contact Karla Sartori, MED3OOO Corporate Marketing, at 412-937-8887 or .
CONTACT:
Karla Sartori
412-937-8887 ext. 325

This release was issued through eReleases(TM). For more information, visit .
MED3OOO Group, Inc.

WINFIELD, Ill., July 11 /PRNewswire-USNewswire/ — Central DuPage Hospital (CDH) of Winfield, Ill. has been ranked #47 in Orthopedics in U.S. News’ 2008 publication of America’s Best Hospitals, accessible today online at and on sale at newsstands Monday, July 14.
Out of the 5,453 hospitals reviewed, only 170 medical centers nationwide ranked high enough by the 2008 America’s Best Hospitals standards to be listed in one or more of the 16 specialties.
“Talent and money alone don’t put hospitals in the rankings,” says Best Hospitals editor Avery Comarow. “The truly best hospitals are never satisfied,” he said. “Of course they have high medical standards. But the emphasis is not only on doing well, but always doing better.”
“Achieving this recognition for the second consecutive year is a testament to our entire hospital community. Our patients benefit from fine surgeons, excellent nurses and staff, and, our ongoing commitment to state-of-the-art technology,” says Luke McGuinness, Chief Executive Officer of CDH. “Investments in new programs and expanded capacity are rooted in our desire to meet the needs of our patients and physicians alike. It is always an honor to be recognized and to know these efforts are well received.”
Methodology
The rankings in 12 of the 16 specialties weigh three elements equally: reputation, death rate and a set of care-related factors such as nursing and patient services. In these 12 specialties, hospitals have to pass through several gates to be ranked and considered a Best Hospital:
1. The first gate determines whether a hospital is eligible to be ranked at all by requiring that any of three conditions be met — to be a teaching hospital, to be affiliated with a teaching hospital, or to have at least six important medical technologies from a defined list of 13.
2. The second gate determines whether a hospital is eligible to be ranked in a particular specialty. To be eligible, the hospital had to either have at least a specified volume in certain procedures and conditions over three years, or had to have been nominated in our yearly specialist survey.
3. The third gate is whether a hospital does well enough to be ranked, based on its reputation, death rate, and factors like nurse staffing and technology.
This award is one of many achieved by Central DuPage Hospital within the last two years. The 361-bed facility has been recognized as a Thomson Reuters 100 Top Hospital in 2006 and 2007, has received awards in Clinical Excellence, Coronary Intervention, Gastrointestinal Surgery, Gastrointestinal Care, Pulmonary Care, Stroke Care, Critical Care, Patient Safety and Joint Replacement from HealthGrades and has earned the Hospital and health Networks Most Wired Award.
About the U.S. News Media Group
The U.S. News Media Group is a multi-platform digital publisher of news and analysis which includes U.S.News & World Report magazine, and . Focusing on Health, Money & Business, Education and Public Service/Opinion, the U.S. News Media Group has earned a reputation as the leading provider of service news and information that improves the quality of life of its readers. The U.S. News Media Group’s signature franchises include its News You Can Use(R) brand of journalism and its “America’s Best” series of consumer guides that include rankings of colleges, graduate schools, hospitals, health plans and more.
About Central DuPage Hospital
Central DuPage Hospital (CDH) is a nationally recognized 361-bed facility located in Winfield, Illinois, a suburb west of Chicago. It is the third most active hospital in Illinois performing total joint replacements. CDH is a leading center for surgical innovations and was one of the first institutions in the nation to offer robotic-assisted surgery, minimally invasive spine surgery with bio-engineered bone protein and was the first Level III Neonatal Intensive Care Unit in DuPage County.
The hospital is part of an interdependent network of health-care organizations and services, including convenient care centers, occupational health services and a full range of options for senior living, home health and hospice care. To learn more information about CDH visit or call (630) 933-4CDH.
Central DuPage Hospital

BOULDER, Colo., July 9 /PRNewswire/ — People are more likely to be active in the summertime — hiking, biking, swimming, or just relaxing in the backyard — than at any other time of the year. And the sun’s rays and myriad pesky flying insects are at their peak. Natural Solutions: Vibrant health Balanced Living magazine has compiled a list of nontoxic sunscreens and insect repellents just in time for the dog days ahead. The August issue, on newsstands now, reports in the articles “Slather, Play, Repeat: Sun Encounters of the Safest Kind” and “A Better Buzzkill” that there are healthier ways to protect your skin when it’s under attack.
“We should all use sunscreen on a regular basis this time of year, but even some natural sunscreens contain ingredients we should avoid. Chemicals and nanoparticles of zinc oxide and titanium dioxide — created from nanotechnology — are tiny enough to be absorbed into the skin,” says Linda Sparrowe, editor-in-chief of Natural Solutions. “While zinc oxide and titanium dioxide are regarded as safe and effective sunscreens, this article highlights potential problems when they are ‘nanoized’ and offers a list of alternative products.”
Natural Solutions’ editors tested seven sunscreens devoid of nanoparticles. Their three favorite brands based on absorbability include Lavera Family Sun Spray SPF 15, Lotus Moon Sage Sun Protective Creme SPF 25, and Alba Botanica Fragrance Free Mineral Sunscreen SPF 18.
DEET, a pesticide developed by the U.S. Army in 1946, is the active ingredient in most conventional insect repellents. Yet the EPA says exposure to DEET should be brief, alluding to its toxicity. For a nontoxic, bug-free summer, head to the natural products store for lemon-eucalyptus oil, citronella oil, neem oil, and lavender oil, all of which throw bugs off the human scent and make skin taste unappealing.
To read these stories, visit naturalsolutionsmag.com.

About Natural Solutions

Natural Solutions: Vibrant Health, Balanced Living, formerly Alternative Medicine magazine, has been the trusted voice in the natural health arena for more than 14 years. Natural Solutions guides and inspires its readers to make informed decisions about their health and well-being in all aspects of their lives.
For more information or to speak with Editor-in-Chief Linda Sparrowe, who is a knowledgeable (and lively) source for natural health topics, contact Kathy O’Neill at 773.401.0714 or .
Natural Solutions

LOS ALAMITOS, Calif., July 7 /PRNewswire/ — Traditional medicine attempts to treat menopausal symptoms with drugs or hormones. However, they don’t handle underlying causes. As a result, menopausal women may have to suffer.
There is another alternative. Through Holistic health Solutions, a woman may significantly decrease her menopausal symptoms using a variety of all-natural treatments.
“The goal of holistic healing is to remove or reduce all of the causes of a health problem instead of just masking the symptom. Furthermore, I teach my patients to do many of the therapies at home to maintain their results,” explains Dr. Stewart Edrich, DC.
As for menopause, Edrich begins by addressing the functioning of a woman’s liver and adrenals. The liver must be “de-toxified” and the adrenals must be strong. These organs are key to hormonal balance.
“Giving a women more hormones is not always the right place to start.” Edrich explains, “The trick lies in the efficiency of the other organs. If you make too much cortisol “The belly fat hormone” your body will “steal” the sex hormones to make more cortisol, and if the liver is too toxic it won’t be able to re-cycle used estrogen which throws off the hormonal balance.”
Edrich believes, “First use holistic processes that focus on diet and lifestyle, use natural methods based on Applied Kinesiology and 3000 years of Chinese medicine to determine function; such as location and types of symptoms, condition of the tongue hair and fingernails. If the problem is not resolving then saliva, blood, stool or urine tests may give additional data.”
For treatment first he uses diet, exercise and lifestyle, then uses herbs and supplements along with postural balancing and acupressure.
Even though detoxification and tonification seem simple, most people will not be able to do it on their own without professional guidance and coaching.
During the course of Edrich’s holistic practice (since 1992), many women in the Los Angeles and Orange County area have benefited through his methods. Many got rid of menopausal symptoms, but they also had an opportunity to address other their health problems such as weight gain, insomnia or depression and pain.
Edrich says, “My approaches focus on making you healthier, and healthier people feel better.”
For more information please visit:
Holistic health Solutions

NEWPORT NEWS, Va., July 1 /PRNewswire/ — Solis Women’s Health, with eight centers across the Dallas-Fort Worth Metroplex devoted entirely to mammography and breast imaging, announced today that it is adding molecular imaging to the diagnostic tools it has available in its DFW locations. This exciting technology is performed with the Dilon 6800, a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI). It is initially being implemented at Solis’ Central Plano location, with further implementations planned at Solis locations throughout the Metroplex.
BSGI is a molecular breast imaging technique that can see lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than normal, healthy cells and generally appear as “hot spots” on the BSGI image.
Solis has been using the Dilon 6800 in its Solis-Bertrand Breast Center in Greensboro, N.C., for over a year. Molecular imaging will be used as a part of Solis’ advanced imaging program for breast diagnosis, which also includes the use of breast MRI, when appropriate.
“BSGI has proven to be an important adjunct to mammography and ultrasound in the diagnosis of breast cancer at the Solis-Bertrand Center, and we are excited to be the first in the Metroplex to offer this important advance in care,” said Brad Hummel, CEO of Solis.
“At Solis our commitment is to the women of our communities, and this commitment extends to selecting technologies that demonstrate diagnostic value in our mission to diagnose cancers when they are small and at their most treatable. We studied the BSGI extensively at our center in Greensboro, and determined that it offered benefits that we needed to bring to the Metroplex,” said Hummel.
Bob Moussa, CEO of Dilon Technologies added, “We are delighted to have an institution as prestigious as Solis Women’s health include our advanced technology as part of their diagnostic offering. It speaks volumes for their commitment to enhancing the standard of health care in the communities in which they operate. By working closely together, Solis and Dilon will continue to help the fight against cancer.”
About Solis Women’s Health
Solis Women’s health is a specialized healthcare provider focused exclusively on the screening and diagnosis of breast cancer. Headquartered in Austin, Texas, Solis operates eight north central Texas facilities; the Solis-Bertrand Breast Center in Greensboro, N.C.; Solis-BenOra Imaging in Phoenix, Ariz.; and 10 MedTech Mammography Centers in Phoenix and Tucson, Ariz.; and has several additional sites under development in markets across the United States. Solis provides a complete range of breast health services including screening mammography, diagnostic mammography, computer-aided detection, breast ultrasound, bone densitometry and stereotactic and ultrasound-guided biopsy, breast specific gamma imaging and breast MRI. More information is available at .
About Dilon Technologies
Dilon Technologies Inc. is bringing innovative new medical imaging products to market. Dilon’s cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit .
Dilon Technologies Inc.